These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38230638)

  • 1. Recent advances in the synthesis and medicinal perspective of pyrazole-based α-amylase inhibitors as antidiabetic agents.
    Khator R; Monga V
    Future Med Chem; 2024 Jan; ():. PubMed ID: 38230638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Insight of Alpha-amylase Inhibitors as a Valuable Tool in the Management of Type 2 Diabetes Mellitus.
    Bashary R; Vyas M; Nayak SK; Suttee A; Verma S; Narang R; Khatik GL
    Curr Diabetes Rev; 2020; 16(2):117-136. PubMed ID: 31237215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An insight on medicinal attributes of 1,2,3- and 1,2,4-triazole derivatives as alpha-amylase and alpha-glucosidase inhibitors.
    Sharma A; Dubey R; Bhupal R; Patel P; Verma SK; Kaya S; Asati V
    Mol Divers; 2023 Sep; ():. PubMed ID: 37733243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyrazole scaffold-based derivatives: A glimpse of α-glucosidase inhibitory activity, SAR, and route of synthesis.
    Firdaus JU; Siddiqui N; Alam O; Manaithiya A; Chandra K
    Arch Pharm (Weinheim); 2023 May; 356(5):e2200421. PubMed ID: 36617511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and In Vitro α-Amylase and α-Glucosidase Dual Inhibitory Activities of 1,2,4-Triazole-Bearing
    Khan I; Rehman W; Rahim F; Hussain R; Khan S; Rasheed L; Alanazi MM; Alanazi AS; Abdellattif MH
    ACS Omega; 2023 Jun; 8(25):22508-22522. PubMed ID: 37396210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New pyrazole-tetrazole hybrid compounds as potent α-amylase and non-enzymatic glycation inhibitors.
    Oulous A; Daoudi NE; Harit T; Cherfi M; Bnouham M; Malek F
    Bioorg Med Chem Lett; 2022 Aug; 69():128785. PubMed ID: 35569687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of novel inhibitors of α-amylase based on the thiazolidine-4-one skeleton containing a pyrazole moiety and their configurational studies.
    Kumar P; Duhan M; Kadyan K; Sindhu J; Kumar S; Sharma H
    Medchemcomm; 2017 Jul; 8(7):1468-1476. PubMed ID: 30108858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trifluoromethylated Flavonoid-Based Isoxazoles as Antidiabetic and Anti-Obesity Agents: Synthesis, In Vitro
    Algethami FK; Saidi I; Abdelhamid HN; Elamin MR; Abdulkhair BY; Chrouda A; Ben Jannet H
    Molecules; 2021 Aug; 26(17):. PubMed ID: 34500647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, antidiabetic activity and molecular docking study of rhodanine-substitued spirooxindole pyrrolidine derivatives as novel α-amylase inhibitors.
    Toumi A; Boudriga S; Hamden K; Sobeh M; Cheurfa M; Askri M; Knorr M; Strohmann C; Brieger L
    Bioorg Chem; 2021 Jan; 106():104507. PubMed ID: 33288322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Applications of the Multicomponent Synthesis for Bioactive Pyrazole Derivatives.
    Becerra D; Abonia R; Castillo JC
    Molecules; 2022 Jul; 27(15):. PubMed ID: 35897899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, molecular docking and QSAR study of thiazole clubbed pyrazole hybrid as α-amylase inhibitor.
    Duhan M; Singh R; Devi M; Sindhu J; Bhatia R; Kumar A; Kumar P
    J Biomol Struct Dyn; 2021 Jan; 39(1):91-107. PubMed ID: 31838966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular dynamics simulation for screening phytochemicals as α-amylase inhibitors from medicinal plants.
    Sharma P; Joshi T; Joshi T; Chandra S; Tamta S
    J Biomol Struct Dyn; 2021 Oct; 39(17):6524-6538. PubMed ID: 32748738
    [No Abstract]   [Full Text] [Related]  

  • 13. Exploring biological efficacy of novel benzothiazole linked 2,5-disubstituted-1,3,4-oxadiazole hybrids as efficient α-amylase inhibitors: Synthesis, characterization, inhibition, molecular docking, molecular dynamics and Monte Carlo based QSAR studies.
    Duhan M; Kumar P; Sindhu J; Singh R; Devi M; Kumar A; Kumar R; Lal S
    Comput Biol Med; 2021 Nov; 138():104876. PubMed ID: 34598068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of Novel Coumarin Derivatives as Potential Dual Inhibitors against α-Glucosidase and α-Amylase for the Management of Post-Prandial Hyperglycemia via Molecular Modelling Approaches.
    Patil SM; Martiz RM; Satish AM; Shbeer AM; Ageel M; Al-Ghorbani M; Ranganatha L; Parameswaran S; Ramu R
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35745030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crude extract and isolated bioactive compounds from Notholirion thomsonianum (Royale) Stapf as multitargets antidiabetic agents: in-vitro and molecular docking approaches.
    Mahnashi MH; Alqahtani YS; Alqarni AO; Alyami BA; Jan MS; Ayaz M; Ullah F; Rashid U; Sadiq A
    BMC Complement Med Ther; 2021 Oct; 21(1):270. PubMed ID: 34706708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening of antidiabetic and antioxidant activities of medicinal plants.
    Shori AB
    J Integr Med; 2015 Sep; 13(5):297-305. PubMed ID: 26343100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of α-glucosidase and α-amylase inhibitory effects of phenoxy chalcones and molecular modeling studies.
    Kurşun-Aktar BS; Adem Ş; Tatar-Yilmaz G; Hameed ZAH; Oruç-Emre EE
    J Mol Recognit; 2023 Nov; 36(11):e3061. PubMed ID: 37720970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and Molecular Docking Studies of Alkoxy- and Imidazole-Substituted Xanthones as α-Amylase and α-Glucosidase Inhibitors.
    Aguila-Muñoz DG; Vázquez-Lira G; Sarmiento-Tlale E; Cruz-López MC; Jiménez-Montejo FE; López Y López VE; Escalante CH; Andrade-Pavón D; Gómez-García O; Tamariz J; Mendieta-Moctezuma A
    Molecules; 2023 May; 28(10):. PubMed ID: 37241920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feruloyl Sucrose Esters: Potent and Selective Inhibitors of α-glucosidase and α-amylase.
    Devaraj S; Yip YM; Panda P; Ong LL; Wong PWK; Zhang D; Ali Y; Judeh Z
    Curr Med Chem; 2022; 29(9):1606-1621. PubMed ID: 34455958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in silico studies of fluorinated 2,3-disubstituted thiazolidinone-pyrazoles as potential α-amylase inhibitors and antioxidant agents.
    Ganavi D; Ramu R; Kumar V; Patil SM; Martiz RM; Shirahatti PS; Sathyanarayana R; Poojary B; Holla BS; Poojary V; Kumari KPN; Shivachandra JC
    Arch Pharm (Weinheim); 2022 Mar; 355(3):e2100342. PubMed ID: 34923670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.